NCT01334255 - iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

July 31, 2012

Conditions

Pigment Epithelial Detachment

Interventions

DRUG

iSONEP (sonepcizumab/LT1009)

Up to 3 doses of iSONEP given monthly will be administered as intravitreous injections in the ophthalmologist's office.

Trial Locations (5)

Associates in Ophthalmology, West Mifflin

Palmetto Retina Center, West Columbia

Center For Retina & Macular Disease, Winter Haven

Retina Research Center, Austin

Retina Research Institute of Texas, Abilene